Expensive insulins, pen devices dominate U.S. diabetes careOctober 19, 2021Business of MedicineEndocrinology
Synthetic chemical in consumer products linked to early death, study saysOctober 12, 2021EndocrinologyPediatricsMixed Topics
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinitionSeptember 20, 2021CardiologyEndocrinology
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEFAugust 31, 2021CardiologyEndocrinology
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HFAugust 27, 2021CardiologyEndocrinology
US Preventive Services Task Force lowers diabetes screening age for overweightAugust 24, 2021CardiologyEndocrinology
SGLT2 inhibitor use rising in patients with DKDAugust 23, 2021CardiologyEndocrinologyRenal & Genitourinary
Pandemic derails small success in lowering diabetes-related amputationsAugust 19, 2021EndocrinologyNeurologyDiversity in MedicinePain
